Analyst Ratings for Amneal Pharmaceuticals (AMRX)
AMRX Rating Summary
AMRX Price Target Summary
- Highest: $27.00 (Oppenheimer)
- Lowest: $13.00 (Piper Sandler)
- Average: $20.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.43 (+6.5%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 65%
Avg. $ Target:
$20.43 (+6.5%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2026 | Oppenheimer | Les Sulewski | New Coverage | Outperform (N/A) |
27.00 (N/A) |
19.50 (19.18) |
-1.64% | Details |
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
23.00 (N/A) |
17.05 (19.18) |
12.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
